New Zealand Committee on Adverse Drug Reactions: Ninth Annual Report 1974.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006760:Hospitalization; D006784:Hospitals, Teaching; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007223:Infant; D008297:Male; D008875:Middle Aged; D009520:New Zealand; D009582:Nitrofurantoin / Q000009:adverse effects; D010096:Oxprenolol / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D013390:Succinylcholine / Q000009:adverse effects; D013420:Sulfamethoxazole / Q000009:adverse effects; D014295:Trimethoprim / Q000009:adverse effects
D000970:Antineoplastic Agents; D007004:Hypoglycemic Agents; D010096:Oxprenolol; D009582:Nitrofurantoin; D014295:Trimethoprim; D010653:Phenylbutazone; D013390:Succinylcholine; D013420:Sulfamethoxazole; D006221:Halothane